Approach to Liver Function Test Abnormalities
Abstract
Liver function test abnormality is a common clinical situation, in case of delay in early diagnosis and treatment it can end up with severe morbidity and even mortality. The important points in approach to the patient with liver function abnormality are; the duration of liver function abnormality, the degree of liver function test elevation, the reversibility, the other accompanying biochemical test abnormalities, alcohol and drug use history, history of previous jaundice and all the patients should be evaluated according to their age groups separately.
References
- Lott JA, Wolf PL. Alanine and aspartate aminotransferase (ALT and AST). Clinical enzmyology: a case-oriented approach. Chicago, Yearbook Medical Publishers, 1986, 131-138.
- Ruhl CE, Everhart JE. Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology 2010;138:1346-56.
- Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1-10.
- Piton A, Poynard T, Imbert-Bismuth F, Khalil L, Delattre J, Pelissier E, et al. Factor sassociated with serum alanine transferase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998;27:1213-9.
- Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology 2012;55:447-54.
- Litin SC, O’Brien JF, Pruett S, Forsman RW, Burritt MF, Bartholomew LG, et al. Macroenzymes as a cause of unexplained elevation of aspartate aminotransferase. Mayo Clin Proc 1987;62:681-7.
- Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol 1992;87:831-6.
- Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z. Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol 1998;26:183-6.
- Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003;82:392-406.
- Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507-39.
- Sonsuz A. Karaciğer fonksiyon bozukluklarına yaklaşım. İ.Ü. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri. 2007;58:69-78.
- Nannipieri M, Gonzales C, Baldi S, Posades R, Williams K, Haffner SM, et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 2005; 28: 1757-62.
- Moss DW. Physicochemical and pathophysiological factors in the release of membrane-bound alkaline phosphatase from cells. Clin Chim Acta 1997;257:133-140.
- Cabrera-Abreu JC, Green A. Gamma-glutamyl trasferase: value of its measurement in pediatrics. Ann Clin Biochem 2002;39:22-5.
- Price CP, Alberti KGMM. Biochemical Assessment of Liver Function. In “Liver and Biliary Disease-Pathophysiology, Diagnosis, Management”. Wright R, Alberty KGMM, Karran S, Millward-Sadler GH (eds). London, W.B. Saunders. 1979; 381-416.
- Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association for the Study of Liver Disease, and American Colllege of Gastroenterology. Gastroenterology 2012;142:1592-1609.
- Friedman LS, Chopra S, Travis AC. Approach to the patient with abnormal liver biochemical and function tests. Upto date 2014.
